Pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto

Details for Australian Patent Application No. 2007305235 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Strah-Pleynet, Sonja; Choi, Jin sun Karoline; Dosa, Peter I.; Smith, Brian M.; Cherrier, Martin C.; Ullman, Bret; Xiong, Yifeng; Teegarden, Bradley

Agent FB Rice

Pub. Number AU-B-2007305235

PCT Pub. Number WO2008/042388

Priority 60/849,070 03.10.06 US

Filing date 2 October 2007

Wipo publication date 10 April 2008

Acceptance publication date 17 May 2012

International Classifications

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/042388 Priority application(s): WO2008/042388

17 May 2012 Application Accepted

  Published as AU-B-2007305235

23 August 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 03 Aug 2012 . Address for service in Australia - FB Rice Level 23 44 Market Street Sydney NSW 2000 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007305239-Brilliant white cauliflower

2007305234-PVC/polyester binder for flooring